| Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (NCT02952131) | Healeon Medical Inc | 2016-11-30 |
| Polaris Oncology Survivor Transition (POST) System (NCT02637349) | Polaris Health Directions | 2016-11-30 |
| Status Migrainosus - Differentiating Between Responders and Non-responders (NCT03066544) | Hartford HealthCare | 2016-11-30 |
| A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors (NCT02913313) | Bristol-Myers Squibb | 2016-11-30 |
| A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics (NCT02953639) | Hoffmann-La Roche | 2016-11-30 |
| BENDITA BEnznidazole New Doses Improved Treatment and Associations (NCT03378661) | Drugs for Neglected Diseases | 2016-11-30 |
| Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. (NCT02970942) | Novo Nordisk A/S | 2016-11-30 |
| Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC) (NCT03416231) | Affiliated Hospital of North Sichuan Medical College | 2016-11-30 |
| A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease (NCT03000569) | Biogen | 2016-11-30 |
| A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 (NCT02983227) | Genentech, Inc. | 2016-11-30 |
| An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib (NCT02955940) | Incyte Corporation | 2016-11-30 |
| Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma (NCT02970981) | NYU Langone Health | 2016-11-29 |
| Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance (NCT02896582) | The Lymphoma Academic Research Organisation | 2016-11-29 |
| Effect of Tadalafil on Cerebral Large Arteries in Stroke (NCT02801032) | Christina Kruuse | 2016-11-29 |
| A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer (NCT02935634) | Bristol-Myers Squibb | 2016-11-29 |
| Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients (NCT03144947) | Gruppo Oncologico Italiano di Ricerca Clinica | 2016-11-29 |
| Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation (NCT02867384) | Dana-Farber Cancer Institute | 2016-11-29 |
| Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir (NCT02902185) | Tang-Du Hospital | 2016-11-29 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis (NCT02943460) | Gilead Sciences | 2016-11-29 |
| Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone (NCT02880319) | Dana-Farber Cancer Institute | 2016-11-29 |
| Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes (NCT02871492) | AiCuris Anti-infective Cures AG | 2016-11-29 |
| A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer (NCT02937818) | AstraZeneca | 2016-11-28 |
| Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC (NCT02808390) | PPM Services S.A. | 2016-11-28 |
| Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) (NCT02955602) | Gilead Sciences | 2016-11-28 |
| Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (NCT03018054) | EA Pharma Co., Ltd. | 2016-11-28 |
| MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT (NCT02931929) | Medical University Innsbruck | 2016-11-28 |
| A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02763319) | Incyte Corporation | 2016-11-28 |
| Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder (NCT02841709) | Idorsia Pharmaceuticals Ltd. | 2016-11-28 |
| Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer (NCT02980341) | Daiichi Sankyo Co., Ltd. | 2016-11-28 |
| A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma (NCT02854839) | GC Cell Corporation | 2016-11-28 |
| A Study of MG1111 in Healthy Children (NCT03375502) | Green Cross Corporation | 2016-11-26 |
| A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics (NCT02960490) | Eisai Co., Ltd. | 2016-11-26 |
| FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC (NCT04034459) | Ludwig-Maximilians - University of Munich | 2016-11-25 |
| Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study (NCT03071653) | University of Cape Town | 2016-11-24 |
| Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer (NCT03086785) | Hebei Medical University Fourth Hospital | 2016-11-24 |
| Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (NCT02977052) | The Netherlands Cancer Institute | 2016-11-24 |
| Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (NCT02856048) | Assistance Publique - Hôpitaux de Paris | 2016-11-23 |
| Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma (NCT02518750) | St. Jude Children's Research Hospital | 2016-11-23 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery (NCT02734537) | ECOG-ACRIN Cancer Research Group | 2016-11-23 |
| Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) (NCT02819479) | Norton Healthcare | 2016-11-23 |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors (NCT02988817) | Genmab | 2016-11-23 |
| Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies (NCT03283670) | Washington University School of Medicine | 2016-11-22 |
| Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NCT02953509) | Gilead Sciences | 2016-11-21 |
| Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing (NCT02786498) | University of Maryland, Baltimore | 2016-11-21 |
| Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma (NCT03243851) | Yong-Kil Hong | 2016-11-21 |
| Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer (NCT02993094) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2016-11-21 |
| Autologous Stem Cell Study for Adult TBI (Phase 2b) (NCT02525432) | The University of Texas Health Science Center, Houston | 2016-11-21 |
| Study of VTD in Waldenstrom's Macroglobulinemia (NCT03335098) | Seoul National University Hospital | 2016-11-21 |
| Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors (NCT02717156) | University of Southern California | 2016-11-21 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers (NCT02908906) | Janssen Research & Development, LLC | 2016-11-21 |
| A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) (NCT02901431) | Hoffmann-La Roche | 2016-11-21 |
| The Influence of Oxytocin on Socio-communicative Sensitivity (NCT03096249) | KU Leuven | 2016-11-21 |
| Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer. (NCT02789657) | Brown University | 2016-11-21 |
| Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention (NCT02896712) | The University of Texas Health Science Center, Houston | 2016-11-18 |
| H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas (NCT02960230) | Sabine Mueller, MD, PhD | 2016-11-18 |
| Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects (NCT02696954) | University of Oxford | 2016-11-18 |
| Phase II Study of Oral Nafithromycin in CABP (NCT02903836) | Wockhardt | 2016-11-18 |
| Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) (NCT02861573) | Merck Sharp & Dohme LLC | 2016-11-17 |
| Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome (NCT02996448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-11-17 |
| Bosutinib in Elderly Chronic Myeloid Leukemia (NCT02810990) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2016-11-17 |
| A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma. (NCT03233152) | Universitair Ziekenhuis Brussel | 2016-11-17 |
| Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS (NCT02921061) | Fred Hutchinson Cancer Center | 2016-11-17 |
| Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041) (NCT02956629) | Merck Sharp & Dohme LLC | 2016-11-16 |
| Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder (NCT02891161) | Monika Joshi, MD | 2016-11-16 |
| Triheptanoin in Mc Ardle (NCT02919631) | Institut National de la Santé Et de la Recherche Médicale, France | 2016-11-16 |
| Evaluation 2% Chlorhexidine Gluconate (NCT03326726) | Medline Industries | 2016-11-16 |
| Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers. (NCT02916940) | Brugmann University Hospital | 2016-11-16 |
| Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss (NCT02997189) | Otonomy, Inc. | 2016-11-15 |
| A Study to Evaluate SHR-1210 in Subjects With Advanced HCC (NCT02989922) | Jiangsu HengRui Medicine Co., Ltd. | 2016-11-15 |
| Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents (NCT02946385) | GlaxoSmithKline | 2016-11-15 |
| The Prevention of Hypotension After Epidural Analgesia After Major Surgery (NCT02722746) | University of Florida | 2016-11-15 |
| A 6 Month Safety Extension Study of MBGS205 (NCT02908074) | Mereo BioPharma | 2016-11-15 |
| Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis (NCT02931838) | Bristol-Myers Squibb | 2016-11-15 |
| Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer (NCT02899078) | University of California, Davis | 2016-11-15 |
| Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery (NCT02884648) | M.D. Anderson Cancer Center | 2016-11-15 |
| GSK2982772 Study in Subjects With Ulcerative Colitis (NCT02903966) | GlaxoSmithKline | 2016-11-15 |
| Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease (NCT02980263) | Novartis Pharmaceuticals | 2016-11-15 |
| Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (NCT02992912) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-11-15 |
| Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria (NCT03157635) | Hoffmann-La Roche | 2016-11-14 |
| Sequential Combo Immuno and Target Therapy (SECOMBIT) Study (NCT02631447) | Fondazione Melanoma Onlus | 2016-11-14 |
| DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis (NCT02973269) | Revance Therapeutics, Inc. | 2016-11-14 |
| A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease (NCT03007888) | Impax Laboratories, LLC | 2016-11-14 |
| Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02713386) | NRG Oncology | 2016-11-14 |
| A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients (NCT04237805) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2016-11-14 |
| Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion (NCT03127670) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2016-11-14 |
| Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03020329) | Sun Yat-sen University | 2016-11-14 |
| Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer (NCT02912572) | Dana-Farber Cancer Institute | 2016-11-14 |
| Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas (NCT02828111) | PellePharm, Inc. | 2016-11-11 |
| Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171) | Canadian Cancer Trials Group | 2016-11-11 |
| Olaparib in Treating Patients With Stage IV Pancreatic Cancer (NCT02677038) | M.D. Anderson Cancer Center | 2016-11-11 |
| Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02901899) | Northwestern University | 2016-11-11 |
| Merestinib In Non-Small Cell Lung Cancer And Solid Tumors (NCT02920996) | Dana-Farber Cancer Institute | 2016-11-11 |
| A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women (NCT02956837) | GlaxoSmithKline | 2016-11-10 |
| A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib (NCT02873962) | Dana-Farber Cancer Institute | 2016-11-10 |
| A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy (NCT04302441) | Fudan University | 2016-11-10 |
| Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema (NCT02949024) | Clearside Biomedical, Inc. | 2016-11-10 |
| Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate (NCT02996500) | Pfizer | 2016-11-10 |
| A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma (NCT02951819) | Janssen Scientific Affairs, LLC | 2016-11-09 |
| A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion (NCT02926066) | National Taiwan University Hospital | 2016-11-09 |
| Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection (NCT02765490) | Janssen Research & Development, LLC | 2016-11-09 |